Early Stage
Life Science Investing

We work closely with entrepreneurs to build strong companies in the mid-Atlantic region that are focused on improving human health.

35

Over 35 active portfolio companies and more to come

20

20 exits, most recently Pillo Health

11

11 products with FDA approval